Novel insights into the role of bacterial gut microbiota in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) mostly develops in patients with chronic liver disease, driven by a vicious cycle of liver injury, inflammation, and regeneration. Increasing evidence points to the influence of bacterial gut microbiota influence on chronic liver disease and the development of HCC. We...

Full description

Bibliographic Details
Main Authors: Lei Zhang, Guoyu Qiu, Xiaohui Xu, Yufeng Zhou, Ruiming Chang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Cancer Translational Medicine
Subjects:
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2018;volume=4;issue=6;spage=163;epage=166;aulast=Zhang
Description
Summary:Hepatocellular carcinoma (HCC) mostly develops in patients with chronic liver disease, driven by a vicious cycle of liver injury, inflammation, and regeneration. Increasing evidence points to the influence of bacterial gut microbiota influence on chronic liver disease and the development of HCC. We will review how bacterial gut microbiota contributes to HCC and relevant therapeutic strategies, focusing on alterations of the bacterial gut microbiota at different disease stages and mechanisms by which it contributes to disease progression and HCC development in different types of liver diseases.
ISSN:2395-3977
2395-3012